Diagnostic algorithm of recurrence after organ-preserving surgical treatment of bladder cancer
https://doi.org/10.25694/URMJ.2018.04.136
Abstract
High frequency of recurrence is the main problem of organ-preserving tactics in the treatment of bladder cancer. The article presents the results of sensitivity and specificity analysis of urine cytology, BTA-stat test, ultrasound (transabdominal, transrectal, transurethral) and instrumental methods (cystoscopy, photodynamic diagnostics, microcystoscopy) in the diagnosis of recurrence after organ-saving surgical treatment in patients who underwent organ-saving surgery about bladder cancer at the urological clinic of Kazan State Medical University. An algorithm based on the obtained data has been developed for the diagnosis of recurrent bladder cancer
About the Authors
A. Y. Zubkov
ФГБОУ ВО Казанский государственный медицинский университет
Russian Federation
Russian Federation
I. R. Nuriev
ГАУЗ «Клиника медицинского университета»
Russian Federation
Russian Federation
M. E. Sitdykova
ФГБОУ ВО Казанский государственный медицинский университет
Russian Federation
Russian Federation
References
1. Atsu N, Ekici S, Oge O. et al. False-positive results of the NMP22 test due to hematuria. J.Urol. 2002; 167: 555-558.
2. Soloway M., Safer M., Vaidya A. Contemporary management of stage Tl transitional cell carcinoma of the bladder J. Urol. 2002; 67: 1573-1583.
3. Ships L, Augustin H., Zigeuner R. et al. Is a second transurethral resection justified in patients with newly diagnosed superficial bladder cancer?Eur. Urol. 2000: 37; 111.
4. Malkowicz S. B. Superficial bladder cancer: the role of molecular markers in the treatment of high-risk superficial disease. Semin. Urol. Oncol. 1997; 15: 169.
5. Markus A. et al. Second transurethral resection of superficial transitional cell carcinoma of the bladder - a must even for experienced urologist J. Urol. 2001; 165: 298.
6. Holmang S., Johansson S. et al. Stage Та Т1 bladder cancer: The relationship between findings at first follow up cystoscopy and subsequent recurrence and progression J. Urol. 2002; 167: 1634-1637.
7. Mauritio В., Laurence C., Karlheinz K. et al. Variability in the recurrence rate atfirst follow-up cystoscopy after TUR in stage Та Т1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies Eur. Urol. 2002; 41: 523-531.
8. Kriegmair M., Baumgartner R., Knuechel R. et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence (see comments) J. Urol. 1996; 155: 105-110.
9. Kriegmair M., Stepp H., Baungartner R. et al. Fluorescence controlled transurethral resection of bladder cancer following intravesical application of 5-aminolevulinic acid J. Urol. 1996; 155: 665A.
10. Stein J. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in a large group of patients J. Urol. 1998; 159: 213-237.
11. Allard P., Bernard P., Fradet Y. et al. The early clinical course of primary Ta and T1 bladder cancer Europ. Urol.1998; 81: 692-698.
12. Gomez J.F., Madero R., Solsona E., et al.Predicting non-muscle invasive bladder cancer recurrence and progression in patients treated with Bacillus Calmette-Guerin: The CUETO Scoring Model. J. Urol. 2009; 182: 2195-203.
Review
For citations:
Zubkov AY, Nuriev IR, Sitdykova ME. Diagnostic algorithm of recurrence after organ-preserving surgical treatment of bladder cancer. Ural Medical Journal. 2018;(7):116-121. (In Russ.) https://doi.org/10.25694/URMJ.2018.04.136
Views:
114
Email this article 